Phenotypic spectrum associated with a CRADD founder variant underlying frontotemporal predominant pachygyria in the Finnish population

[1]  M. Pirinen,et al.  Contribution of rare and common variants to intellectual disability in a high-risk population sub-isolate of Northern Finland , 2018, bioRxiv.

[2]  Alicia R. Martin,et al.  Haplotype sharing provides insights into fine-scale population history and disease in Finland , 2017, bioRxiv.

[3]  N. Bahi-Buisson,et al.  Genetics and mechanisms leading to human cortical malformations. , 2017, Seminars in cell & developmental biology.

[4]  M. Gomori,et al.  Homozygous null variant in CRADD, encoding an adaptor protein that mediates apoptosis, is associated with lissencephaly , 2017, American journal of medical genetics. Part A.

[5]  Renzo Guerrini,et al.  Lissencephaly: Expanded imaging and clinical classification , 2017, American journal of medical genetics. Part A.

[6]  E. Puffenberger,et al.  Mutations in CRADD Result in Reduced Caspase-2-Mediated Neuronal Apoptosis and Cause Megalencephaly with a Rare Lissencephaly Variant , 2016, American journal of human genetics.

[7]  W. Dobyns,et al.  Genetic Basis of Brain Malformations , 2016, Molecular Syndromology.

[8]  D. Grozeva,et al.  Exome sequencing of Pakistani consanguineous families identifies 30 novel candidate genes for recessive intellectual disability , 2016, Molecular Psychiatry.

[9]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[10]  Youth Board on Children,et al.  COMMITTEE TO EVALUATE THE SUPPLEMENTAL SECURITY INCOME DISABILITY PROGRAM FOR CHILDREN WITH MENTAL DISORDERS , 2015 .

[11]  W. Dobyns,et al.  Malformations of cortical development: clinical features and genetic causes , 2014, The Lancet Neurology.

[12]  A. Fry,et al.  The genetics of lissencephaly , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[13]  T. Kleefstra,et al.  Making headway with genetic diagnostics of intellectual disabilities , 2014, Clinical genetics.

[14]  I. Fokkema,et al.  The Finnish Disease Heritage Database (FinDis) Update—A Database for the Genes Mutated in the Finnish Disease Heritage Brought to the Next‐Generation Sequencing Era , 2013, Human Mutation.

[15]  L. Valanne,et al.  Frontotemporal pachygyria-two new patients. , 2012, European journal of medical genetics.

[16]  Antti Saari,et al.  New Finnish reference for head circumference from birth to 7 years , 2012, Annals of medicine.

[17]  A. Villunger,et al.  Neuronal caspase 2 activity and function requires RAIDD, but not PIDD , 2012, The Biochemical journal.

[18]  R. Kuzniecky,et al.  A developmental and genetic classification for malformations of cortical development: update 2012 , 2012, Brain : a journal of neurology.

[19]  S. Kumar,et al.  Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice , 2012, Cell Death and Differentiation.

[20]  Kristian Cibulskis,et al.  Genetic Mapping and Exome Sequencing Identify Variants Associated with Five Novel Diseases , 2012, PloS one.

[21]  L. Dunkel,et al.  New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age , 2011, Annals of medicine.

[22]  H. Ropers.  Genetics of early onset cognitive impairment. , 2010, Annual review of genomics and human genetics.

[23]  Arlan Richardson,et al.  Caspase-2 deficiency enhances aging-related traits in mice , 2007, Mechanisms of Ageing and Development.

[24]  R. Guerrini,et al.  Genetic malformations of cortical development , 2006, Experimental Brain Research.

[25]  L. Salmena,et al.  Apoptosis caused by p53-induced protein with death domain (PIDD) depends on the death adapter protein RAIDD. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Norio.  Finnish Disease Heritage I: , 2002, Human Genetics.

[27]  Kenneth Lange,et al.  Use of population isolates for mapping complex traits , 2000, Nature Reviews Genetics.

[28]  Yunping Lin,et al.  Pidd, a new death-domain–containing protein, is induced by p53 and promotes apoptosis , 2000, Nature Genetics.

[29]  A. Chapelle,et al.  The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8 , 1999, Nature Genetics.

[30]  Vishva M. Dixit,et al.  RAIDD is a new 'death' adaptor molecule , 1997, Nature.

[31]  L. Peltonen,et al.  Tracing an ancestral mutation: genealogical and haplotype analysis of the infantile onset spinocerebellar ataxia locus. , 1996, Genome research.

[32]  D. Ledbetter,et al.  Isolation of a Miller–Dicker lissencephaly gene containing G protein β-subunit-like repeats , 1993, Nature.

[33]  K. Narisawa,et al.  Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia. , 1992, The Journal of clinical investigation.

[34]  K. Raivio,et al.  Salla disease , 1983, Neurology.

[35]  K. Raivio,et al.  "Salla disease": a new lysosomal storage disorder. , 1979, Archives of neurology.

[36]  H. van Bokhoven.  Genetic and epigenetic networks in intellectual disabilities. , 2011, Annual review of genetics.

[37]  R. Sorva,et al.  [Evaluation of childhood growth]. , 1985, Duodecim lääketieteellinen aikakauskirja.